POSSIBILITY OF CARCINOGENESIS IN DRUG-INDUCED GINGIVAL HYPERPLASIA

药物引起的牙龈增生有致癌的可能性

基本信息

  • 批准号:
    07807188
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

The growth factors such as transforming growth factor beta (TGF beta) and basic fibroblast growth factor (bFGF) have been shown to be implicated in the processes of carcinogenesis. We have previously reported that TGF beta, bFGF and their receptors might be related to the pathogenesis of drug-induced gingival hyperplasia. In the present study, we examined immunohistochemically the expression of carcinoma-related markers such as p53 protein, Ki-67 antigen and epidermal growth factor erceptor (EGF-R) in the epithelia of 11 hyperplastic gingival tissues induced by nifedipine and phenytoin as well as 5 control tissues. Two specimens out of 4 nifedipine-induced and 4 out of 7 phenytoin-induced hyperplastic tissues revealed the expression of p53 protein in the nuclei of epithelial cells, while no expression of p53 protein was observed in the epithelia of the 5 non-hyperplastic control tissues. The immunoreactions against p53 protein showed sporadic distribution in the suprabasal layrs of hyperplastic gingival epithelium and was comparable to those in non-neoplastic epithelium adjacent to oral carcinoma indicated in the literatures.The mean percentage of epithelial cells experssing Ki-67 antigen in the hyperplastic gingival tissues was also more than 10% higher than that in the controls. The findings were comparable to those of oral dysplastic epithelia studies. The expression of Ki-67 antigen was suppressed in the rete pegs of hyperplastic gingival tissues. On the other hand, the expression of EGF-R in the hyperplastic gingival tissues was as low as the controls.Although gingival hyperplasia is generally thought to be a non-neoplastic disease and fails to show dysplastic epithelia, our results indicate the possibility that drug-induced gingival hyperplasia may be implcated in the initial changes of carcinogenesis.
生长因子如转化生长因子β(TGF β)和碱性成纤维细胞生长因子(bFGF)已被证明与致癌过程有关。我们以前曾报道TGF β、bFGF及其受体可能与药物性牙龈增生的发病机制有关。本研究采用免疫组化方法检测了11例硝苯地平和苯妥英钠诱导的牙龈增生组织及5例正常牙龈组织上皮中癌相关标志物p53蛋白、Ki-67抗原和表皮生长因子受体(EGF-R)的表达。在4例硝苯地平诱导的增生组织和7例苯妥英钠诱导的增生组织中,有2例上皮细胞核中有p53蛋白表达,而在5例非增生对照组织的上皮细胞中未见p53蛋白表达。p53蛋白在增生牙龈上皮的基底上层呈散在分布,与文献报道的癌旁非肿瘤性上皮相似,增生牙龈组织中Ki-67抗原阳性上皮细胞的平均百分比也比对照组高10%以上。这些结果与口腔异型增生上皮研究的结果相当。Ki-67抗原在增生牙龈组织中的表达受到抑制。虽然牙龈增生通常被认为是一种非肿瘤性疾病,并且不能显示上皮发育不良,但我们的研究结果表明,药物诱导的牙龈增生可能参与了癌变的初始变化。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
斉藤恵一: "PhenytoinおよびNifedipineにより誘発された歯肉増殖症についての免疫組織化学的研究-p53タンパク質およびKi-67抗原の発現について-" 口腔衛生学会雑誌. 49(1). 98-108 (1997)
Keiichi Saito:“苯妥英和硝苯地平诱导的牙龈增生的免疫组织化学研究 - p53 蛋白和 Ki-67 抗原的表达 -”口腔健康学会杂志 49(1) (1997)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
斉藤 恵一: "薬物の副作用による歯肉増殖症" Journal of Integrated Medicine.6 (10). 892-893 (1996)
Keiichi Saito:“药物副作用引起的牙龈增生”Journal of Integrative Medicine.6 (10)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Saito K.: "Expression of p53 protein,Ki-67 antigen and epidermel grouth factor receptor in gingival hyperplasin in duced by nifedipine and phenytoin." Journal of Periodontal Research. (in press).
Saito K.:“硝苯地平和苯妥英诱导的牙龈增生中 p53 蛋白、Ki-67 抗原和表皮生长因子受体的表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Saito K,Ikawa K,Mori S,Iwakura M,Sakamoto S: "Expression of p53 protein, Ki-67 antigen and epidermal growth factor receptor in gingival hyperplasia induced by nifedipine and phenytoin" J Periodont Res. (in press). (1997)
Saito K,Ikawa K,Mori S,Iwakura M,Sakamoto S:“硝苯地平和苯妥英诱导的牙龈增生中 p53 蛋白、Ki-67 抗原和表皮生长因子受体的表达”J periodont Res。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAITO Keiichi其他文献

SAITO Keiichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAITO Keiichi', 18)}}的其他基金

Study on development of a novel remedy using green tea catechin for Sjogren's syndrome
绿茶儿茶素治疗干燥综合征新药的开发研究
  • 批准号:
    22592082
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An investigation of cognitive strategies employed in intake interviews by expert practitioners in clinical psychology.
对临床心理学专家在访谈中采用的认知策略的调查。
  • 批准号:
    22500243
  • 财政年份:
    2010
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLES OF SALIVARY GLAND CELLS AS ANTIGEN PRESENTING CELLS IN PATHOGENESIS OF SJOGRENS SYNDROME
唾液腺细胞作为抗原呈递细胞在干燥综合征发病机制中的作用
  • 批准号:
    17592175
  • 财政年份:
    2005
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of visibility estimation model using colors and contrasts
使用颜色和对比度开发可见度估计模型
  • 批准号:
    15500142
  • 财政年份:
    2003
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
INVOLVEMENT OF APOPTOTIC PATHWAY IN PATHOGENESIS OF SJOGRENS SYNDROME
凋亡途径参与干燥综合征的发病机制
  • 批准号:
    14571935
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Ligand Design for Reactivation of Mutant p53 Protein
突变 p53 蛋白重新激活的配体设计
  • 批准号:
    573485-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    University Undergraduate Student Research Awards
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential
癌症中突变 p53 蛋白积累的调节:分子基础和治疗潜力
  • 批准号:
    10315918
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential
癌症中突变 p53 蛋白积累的调节:分子基础和治疗潜力
  • 批准号:
    10406369
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential
癌症中突变 p53 蛋白积累的调节:分子基础和治疗潜力
  • 批准号:
    10622593
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Atomistic mechanism of the oligomerization of p53 protein in DNA scanning
DNA扫描中p53蛋白寡聚化的原子机制
  • 批准号:
    19K23721
  • 财政年份:
    2019
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Reactivation of Mutant p53 Protein Using Bifunctional Zn-binding Molecules
使用双功能锌结合分子重新激活突变 p53 蛋白
  • 批准号:
    489769-2016
  • 财政年份:
    2018
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Reactivation of Mutant p53 Protein Using Bifunctional Zn-binding Molecules
使用双功能锌结合分子重新激活突变 p53 蛋白
  • 批准号:
    489769-2016
  • 财政年份:
    2017
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Targeting stabilized mutant p53 protein
靶向稳定突变 p53 蛋白
  • 批准号:
    9038330
  • 财政年份:
    2013
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting stabilized mutant p53 protein
靶向稳定突变 p53 蛋白
  • 批准号:
    8496336
  • 财政年份:
    2013
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting stabilized mutant p53 protein
靶向稳定突变 p53 蛋白
  • 批准号:
    8827721
  • 财政年份:
    2013
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了